Importantly, it is suspected that primary care physicians (PCPs) are not fully aware of the benefits of GLP-1 RAs shown in CV outcome trials, because these physicians have fewer opportunities for education on CVD and diabetes than specialists [22]. Here, GLP1R is linked to diabetes mellitus.